Contact
Header_1077x260px_About_Profil.jpg

A pathophysiological update of the incretins

GLP-1 agonists: an option for NAFLD?

Profil leads the way in establishing audit trail review procedures in clinical studies using visual data analytics

Free Online Seminar: Audit trail review in clinical studies using visual data analytics

β3-adrenoceptor agonist Mirabegron – a candidate anti-obesity drug?

Even moderate overweight increases the risk for cardiovascular disease, recent study says

SUSTAIN 7 - Semaglutide is superior to Dulaglutide

Alternate –Day Fasting: Any better than other Diets?